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Familial Multiple Cavernous Malformation Syndrome:  
MR Features in This Uncommon but Silent Threat
Marc Mespreuve*,†, Filip Vanhoenacker*,† and Marc Lemmerling†,‡
Cerebral cavernous malformations (CCM) are vascular malformations in the brain and spinal cord. The 
familial form of cerebral cavernous malformation (FCCM) is uncommon. This autosomal dominant pathol-
ogy mostly presents with seizures and focal neurological symptoms. Many persons affected by FCCM 
remain asymptomatic. However, acute hemorrhages may appear over time. 
MRI demonstrates multiple focal regions of susceptibility induced signal loss, well seen on gradient-echo 
sequences (GRE) or even better on susceptibility-weighted imaging (SWI). The presence of a single CCM – 
especially in young persons – without history of FCCM does not exclude this diagnosis. 
Some clinicians also advise an MRI of the spinal cord at the time of diagnosis to serve as a baseline and 
a control MRI of the brain every one to two years. MRI is certainly indicated in individuals with obvious 
new neurologic symptoms. 
Symptomatic siblings should also undergo an MRI of the brain to determine presence, size, and location 
of the lesions. Even in asymptomatic siblings, a screening MRI may be considered, as there may be an 
increased risk of hemorrhage, spontaneous or due to the use of certain medications; the knowledge of 
the presence and the type of these lesions are important.
Surgical removal of a CCM may be justified to prevent a life-threatening hemorrhage. Control MRI may 
reveal the postoperative outcome.
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Introduction
Cerebral cavernous malformations (CCM) are relatively 
common vascular malformations in the brain and spinal 
cord. The familial form of cerebral cavernous malforma-
tion (FCCM) is far less common, accounting for only a small 
minority of cavernous malformations but certainly under-
diagnosed. Patients present with a variation of neurologic 
symptoms, and MR imaging is often the first diagnostic 
test. Our purpose is to review the MR features of FCCM.
Definition
Cerebral cavernous malformations (CCM) or cerebral cav-
ernous angiomas are vascular malformations in the brain 
and spinal cord. In sporadic cases, up to a third of such 
cavernous malformations are multiple.
Familial cerebral cavernous malformation syndrome 
(FCCM) is defined as the presence of multiple CCM (typi-
cally five or more) or the occurrence of CCM in at least two 
members of a family or the presence of a mutation in one 
of the three genes causing FCCM (Table 1) [1,2].
Due to the dynamic nature of CCM, new lesions may 
appear at a rate of between 0.2 and 0.4 lesions per patient-
year [3]. This explains why older patients present with 
diffuse CCM, although young patients may present with 
already diffuse FCCM.
Clinical Findings
The disease most commonly presents with seizures (38%–
55%) and focal neurological deficits (35%–50%) [4]. A 
(recurrent) cerebral haemorrhage or a nonspecific head-
ache are less frequently encountered symptoms. Excep-
tionally, a spontaneous paraplegia may occur. However 
25–50 percent of individuals with CCM in general remain 
symptom free throughout their lives [5]. As many per-
sons affected by FCCM remain asymptomatic, an under-
estimation of its frequency is very probable. Repeated 
minor bleeding from the lesions may cause degeneration. 
Diagnostic Criteria of FCCM (At Least 1 of the Following 
Criteria):
– the presence of multiple CCM (typically 5 or more) 
– the occurrence of CCM in at least two members of a family
–  the presence of a mutation in one of the three genes 
 causing FCCM.
Table 1. Diagnostic criteria of familial cerebral cavernous 
malformation (FCCM) [1,2].
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Resulting dementia and parkinsonism have been reported 
in patients with FCCM [6]. Autopsy revealed that even 90 
percent of persons with a CCM never had symptoms dur-
ing their lives [7]. 
Although cerebral cavernous malformations have been 
reported in children, the majority of patients present with 
symptoms between the second and fifth decades. 
There is a coexistence of 33 percent between cavern-
ous malformations and developmental venous anomalies 
[8,9]. Skin (9%), retinal (5%) and liver lesions have occa-
sionally been reported. Only one of our patients had a 
cutaneous hemangioma [10].
Histology
CCM are composed of closely clustered and enlarged 
capillary channels (called caverns) with a single layer of 
endothelium. The mature vessel wall elements are absent, 
as is the normal intervening brain parenchyma. They 
range from a few millimeters to several centimeters and 
can – due to their dynamic nature – increase (or some-
times decrease) in size and increase in number over time.
Genetics
The suspicion of FCCM by physical examination, family 
history, and brain and spinal cord MRI may be confirmed 
by genetic testing. Three genes are known to cause muta-
tions in FCCM: KRIT-1 (CCM-1), CCM-2, and PDCD-10 
(CCM-3) [11]. At least one other unspecified gene (CCM-4) 
located on the long arm of chromosome three may also 
cause FCCM [12]. Moreover, an association of parenchy-
mal FCCM and dural-based meningiomas has also been 
reported in PDCD10-mutated individuals [13]. 
FCCM is an autosomal dominant disease. Each child 
of an individual with FCCM has a 50 percent chance of 
inheriting the mutation. A much higher incidence of 
FCCM has been reported in Hispanic-American individu-
als of Mexican descent [3,14], in which the proportion of 
familial cases (in the general population only about 20%) 
is estimated to be up to 50 percent. These persons seem 
to be related to a common ancestor with a mutation in the 
KRIT-1 gene [14]. 
MR Features
In typical cases, MRI shows multiple bilateral and dif-
fuse focal regions of susceptibility induced signal loss 
( Figure  1) of variable size, well seen on gradient-echo 
(GRE) sequences, or even better on susceptibility-
weighted imaging (SWI). GRE reveal up to triple the num-
ber of lesions seen on SE T2-WI, and SWI even reveals an 
additional tripling [15,16]. They range in size from a few 
millimeters to several centimeters in diameter. However, 
all T2* sensitive sequences result in a degree of blooming, 
seen as a hazy halo of signal loss around the lesion, and in 
an overestimation of the actual size of the lesions. Bloom-
ing is most obvious around larger lesions (Figure 1).
On MRI, four types of lesions are found (Table 2) [15]. 
A type 1 lesion with hyperintense core on SE T1-WI and 
SE T2-WI suggests recent hemorrhage (Figure 2A and 
2B). Peripheral oedema is best seen on FLAIR-weighted 
images (Figure 2C). A reticulated mixed signal core on SE 
T1-WI and reticulated mixed signal core with surrounding 
hypointense rim on SE T2-WI is compatible with a type 
2 lesion (Figure 3). Hypointense lesion on SE T1-WI and 
hypointense lesion with hypointense rim SE T2-WI and 
blooming on GRE-T2* are referred to as type 3 lesions 
(Figure 4), whereas punctuate hypointense lesions on 
GRE-T2* or SWI, not seen on SE T1-WI, nor on SE T2-WI, 
are designated as type 4 lesions (Figure 5).
The identification of type 1 lesions, with a high frequency 
of recurrent bleeding, and type 4 lesions, which possibly 
represent new lesions, is important. The lesions may dem-
onstrate changing signal. High signal on SE T1- and T2-WI 
centrally with a variable degree of perilesional oedema, 
best seen on fluid attenuated inversion recovery (FLAIR) 
sequences, suggests a more recent bleeding. The clinical sig-
nificance of small lesions seen on MRI remains unknown. 
However, detection of multiple lesions is helpful in dis-
tinguishing CCM from FCCM. Moreover, the meticulous 
evaluation of the number, location, and size of the lesions 
is important, as there may be an increased risk of hemor-
rhage with certain analgesic medications (nonsteroidal 
anti-inflammatory drugs) and the frequently used acetyl-
salicylic acid. The risk-benefit of medications that increase 
the frequency of hemorrhage (heparin and coumarin-type 
drugs) should be weighed thoroughly before use.
CCM can be multiple (in up to a third of the patients). 
However, in FCCM the number of cavernomas is higher, 
typically five or more [3]. Hundreds of lesions may be 
identified, normally increasing with the person’s age. 
However, young patients may already show numerous 
CCM (Figure 6).
Figure 1: FCCM. Axial SWI. Bilateral diffuse presence of 
multiple focal regions of susceptibility-induced signal 
loss of variable size. Blooming is most obvious around 
the two larger lesions. 
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Figure 2: FCCM Type 1 lesion. Axial SE T1-WI (A), TSE T2-WI (B), and FLAIR (C). Hyperintense core on SE T1-WI (A) and 
SE T2-WI (B) suggests recent hemorrhage. Peripheral oedema is best seen on FLAIR image (C).
FCCM SE T1-WI (T)SE T2-WI GRE-T2* SWI Clinical Correlation Histopathology
Type 1
– Acute hemorrhage 
–  High frequency of 
bleeding relapse
Subacute hemorrhage
Type 2
Lesions with hemor-
rhages and thromboses 
of varying ages
Type 3
possibly represent 
new lesions
Chronic hemorrhage 
with hemosiderin 
within and around the 
lesion
Type 4 Not visible Not visible Tiny CCM or telangi-
ectasia
LEGEND
Density in relation to 
the surrounding brain 
parenchyma
Part and form  
of the lesion
Hyperintense
Punctate lesion
Isointense
Core
Hypointense
Rim
Surroundings (blooming)
Table 2: FCCM types of lesions on different MRI sequences and correlation with clinical correlation and 
histopathology [11].
Note: SE = spin echo, GRE = gradient echo, SWI = susceptibility-weighted imaging.
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Lesions may be located either supratentorially (75%) 
or infratentorially (25%) [3] (Figure 7). Almost half of 
the infratentorial lesions occur in the brainstem, and 
these are frequently associated with symptoms related to 
hemorrhage. Cavernous malformation can lead to death 
from severe intracranial hemorrhage, particularly when 
located in the brainstem [17]. MRI is a useful tool to assess 
evolution of the number of CCM over time (Figure 8). 
Screening MRI brain examinations of family members is 
useful to detect infra- and supratentorial lesions in the 
brain (Figure 6).
Lesions may be detected only occasionally in the spinal 
cord (about 5%). Secondary superficial siderosis [18,19] is 
exceptional in superficially located lesions. The presence 
of a single (or less than five) CCM – especially in young 
persons – without a history of FCCM does not exclude 
this diagnosis at all (Figure 3). MRI evaluation over time 
shows the appearance of new lesions and of acute (often 
asymptomatic) hemorrhages (0.7% lesions per patient-
year) that change in signal intensity and increase in size 
over time [20]. In children, hemorrhage with an aggressive 
presentation may be more likely. 
Figure 3: FCCM Type 2 lesion located in the brainstem. Axial SE T1-WI (A) and TSE T2-WI (B), sagittal SE T1-WI before 
(C) and after gadolinium contrast (D). Twenty-year-old patient with known FCCM (daughter of a Krit-I positive patient 
with FCCM), who presented with only two CCM, of whom one large lesion was located in the brainstem. The lesion 
shows a reticulated mixed signal core on SE T1-WI and reticulated mixed signal core with surrounding hypointense 
rim on SE T2-WI.
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Figure 4: FCCM Type 3 lesion (arrows). Axial SE T1-WI (A) and TSE T2-WI (B). Hypointense lesion on SE T1-WI (A) and 
hypointense lesion with surrounding hypointense rim on TSE T2-WI (B).  
Figure 5: FCCM Type 4 lesion. Axial SE T1-WI (A), TSE T2-WI (B) and SWI (C). Multiple punctuate hypointense lesions 
(arrows) on SWI (C), not seen on SE T1-WI (A), nor on TSE T2-WI (B).
Figure 6: These axial SWI respectively at the level of the brainstem (A), basal ganglia (B), and semioval center (C), per-
formed on the occasion of a familial screening in a 29-year-old daughter of a patient (figure 1, Krit-I positive) with 
FCCM shows already multiple (only the largest lesion at the different levels marked with an arrow) infratentorial and 
supratentorial cavernomas with typical signal loss.
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Figure 7: FCCM location in the brain in two patients ((A) and (B–D)). Axial SWI. Presence of multiple (A) supratentorial 
and (B–C) infra- and (D) supratentorial lesions.
Figure 8: Evolution of the number of lesions in FCCM. Axial TSE T2-WI (A and C in 2009; B and D in 2013). Appearance 
of at least four new lesions over time (arrows).
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Intravenous gadolinium contrast administration is 
not required for the diagnosis of (F)CCM, but contrast-
enhanced MRI may be useful in identifying more complex 
vascular malformations which are sometimes associated 
with CCM. It may also help to distinguish CCM from other 
types of vascular brain malformations such as capillary tel-
angiectasia, aneurysms, and arteriovenous malformations 
and are indicated if surgical resection is considered (detec-
tion of the venous drainage in order to preserve it). CCM 
are rarely visualized on angiography because of the small 
size of the afferent vessels, the presence of thrombosis, 
and the relatively low flow in a CCM.
Some clinicians advocate MRI of the spinal cord at the 
time of diagnosis to serve as a baseline for future follow-
up. A control MRI of the brain every one to two years (GRE 
or SWI) is indicated, also in individuals with obvious new 
neurologic symptoms. Interpretation may be difficult, as 
new lesions may be asymptomatic. (Symptomatic) siblings 
should undergo MRI of the brain to determine presence, 
size, and location of lesions. 
Figure 9: Capillary telangiectasia in the brainstem (arrows) Axial SE T1-WI (A), TSE T2-WI (B), GRE-T2*(C) and SE T1-WI 
after gadolinium contrast (D). The lesion is not visualized on T1-WI (A). On T2-WI, there is a slightly increased signal 
intensity (B), whereas the lesion is of low signal on GRE-T2*(C). After gadolinium contrast (D), there is a faint enhance-
ment in a brush-like pattern.
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Surgical removal of lesions associated with seizures or 
focal deficits from recurrent hemorrhage or mass effect 
may be justified, even when a large number of other 
lesions is present. Follow-up MRI may evaluate postop-
erative outcome (lesion resection, bleeding, loss of brain 
parenchyma).
Differential Diagnosis
All other causes of cerebral microhaemorrhages are to be 
considered. 
Other types of vascular brain malformations consist of 
capillary telangiectasias (Figure 9), aneurysms, and arte-
riovenous malformations (Figure 10).
In cerebral amyloid angiopathy (Figure 11), numerous 
small foci may have a similar imaging appearance, with 
a predilection, however, for the peripheral subcortical 
white matter. There may also be a history of prior (larger) 
lobar haemorrhage or superficial siderosis.
(Chronic) hypertensive encephalopathy has a predilec-
tion for the region of the basal ganglia (Figure 12).
In diffuse axonal injury (Figure 13), there is a history of 
severe trauma, and the lesions have a typical distribution 
at the borders between the cortical grey matter and the 
underlying white matter.
Neurocysticercosis lesions are more uniform and 
smaller in size; they may calcify by time and are typically 
Figure 10: Arteriovenous malformation. Coronal SE T1-WI. Typical arterial (A) and venous component.
Figure 11: Cerebral amyloid angiopathy. Axial SE T1-WI (A), TSE T2-WI (B) and GRE-T2*(C). Numerous small foci of uni-
form size and susceptibility-induced signal loss with a predilection for the peripheral subcortical white matter, best 
seen on GRE-T2* (or SWI).
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Figure 12: Hypertensive central hemorrhage in patient with severe hypertension. CT (acute fase) (A) and follow-up MRI 
with SE T1-WI (B), TSE T2-WI (c) and SWI (D). Acute cerebral hemorrhage (A). Parenchymal defect (B) and focus of low 
signal with susceptibility-induced signal loss (C, D) best seen on SWI.
Figure 13: Diffuse axional injury. CT (A) and GRE-T2*(B, C). Multiple small foci of high density (A) corresponding with 
(arrows) small foci of low signal intensity (B, C) at the borders between the cortical grey and white matter.
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more regularly delineated. CT or quantitative suscepti-
bility mapping [21] on MRI may confirm the calcifications. 
Radiation-induced cavernous malformations are radio-
logically and even pathologically indistinguishable from 
FCCM [22]. Anamnesis of previous radiation (frequently 
during childhood) may reveal the diagnosis.
More rare are hemorrhagic metastases (Figure 14) 
and de novo bleeding in cerebral vasculitis and radiation 
vasculopathy.
Therapy
Microsurgical removal of a CCM lesion may be justified 
if associated with seizures or focal deficits from recurrent 
hemorrhage or mass effect. To reveal the structural and 
the functional abnormalities of a seizure, the data from 
EEG, MRI, and SPECT may be focused and integrated. The 
spatial relationships may be demonstrated by co-register-
ing images of the abnormalities on the MRI. A recent tech-
nique of subtraction known as ictal SPECT co-registered 
Figure 14: Hemorrhagic metastases. GRE-T2*(A), SE T1-WI (B), and SE T1-WI (C, D) after contrast. Small focus of low sig-
nal (A) in the pons (arrow) with faint contrast enhancement (C) (arrow). Presence of multiple, supratentorial, nodular 
hemorrhagic (B), and enhancing lesions (D). 
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to MRI (SISCOM) may reveal a hyperperfusion focus. The 
SISCOM focus and its relationship to the brain may serve 
as a map for subsequent surgical resection. A follow-up 
MRI is an excellent technique to monitor the postopera-
tive outcome. MRI control after surgery in a patient with 
CCM traditionally shows complete resection, a minimal 
loss of brain parenchyma, and a small marginal region of 
susceptibility artifact (Figure 15).
Conclusion
The familial form of cerebral cavernous malformation 
is uncommon. However, as this autosomal dominant 
pathology presents with a variety of neurological symp-
toms and as, on the other hand, many persons affected 
by FCCM remain asymptomatic, radiologists should 
include FCCM in their differential diagnosis. The pres-
ence of a single CCM in an individual, even without a 
history of FCCM, does not exclude this diagnosis, and a 
control MRI of the brain after one to two years is advised. 
MRI with gradient-echo sequences (GRE) or even prefer-
ably susceptibility-weighted imaging (SWI) of the brain 
is indicated for the diagnosis and to serve as a baseline 
examination. The identification of the type of lesions is 
important to evaluate the risk of bleeding relapse. The 
knowledge of the presence of FCCM is important, as 
there may be an increased risk of hemorrhage with cer-
tain medications. Control MRI of the brain is indicated 
over time, certainly with obvious new neurologic symp-
toms, and after surgical removal. Symptomatic and pos-
sibly even asymptomatic siblings may also undergo MRI 
of the brain to determine presence, size, and location of 
the lesions.
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